Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
jYhfKDv5hSj9gtsg